Estimations des analystes de Wall Street pour Aytu BioPharma, Inc. (AYTU): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Consensus des analystes
| Achat fort | 0 |
| Achat | 5 |
| Conserver | 0 |
| Vente | 0 |
| Vente forte | 0 |
| Analystes au total | 5 |
| Note moyenne (1-5) | 1.00 |
Ratios de valorisation
| Prix / Valeur comptable | 0.58 |
| EV / EBITDA | -0.73 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $2.6M | $3.2M | $3.7M | $7.3M | $27.6M | $65.6M | $96.7M | $107.4M | $65.2M | $66.4M |
| Coût des Ventes | $957076 | $1.4M | $2.1M | $2.2M | $8.3M | $36.4M | $46.4M | $40.8M | $16.1M | $20.6M |
| Marge Brute | $1.6M | $1.8M | $1.6M | $5.1M | $19.4M | $29.2M | $50.3M | $66.6M | $49.1M | $45.8M |
| R&D | $6.3M | $1.3M | $167595 | $589072 | $1.7M | $5.6M | $12.7M | $4.1M | $2.8M | $1.3M |
| Frais Généraux | $8.8M | $17.6M | $17.7M | $19.2M | $31.1M | $55.8M | $69.9M | $70.1M | $42.0M | $38.3M |
| Charges Opérationnelles | $15.8M | $20.7M | $19.5M | $22.0M | $40.5M | $88.1M | $160.2M | $83.7M | $50.6M | $53.7M |
| Résultat Opérationnel | -$21.7M | -$20.1M | -$19.7M | -$16.8M | -$21.1M | -$58.9M | -$109.9M | -$17.1M | -$1.6M | -$7.8M |
| EBITDA | -$21.8M | -$18.1M | -$15.3M | -$14.6M | -$12.2M | -$29.0M | -$28.0M | -$3.3M | $1.4M | -$4.7M |
| Charges d'Intérêt | $5.5M | $2.5M | $749423 | 0 | 0 | 0 | $147.5M | $5.0M | $4.8M | $3.7M |
| Résultat Avant Impôts | -$28.2M | -$22.5M | -$10.2M | -$27.1M | -$13.6M | -$58.0M | -$108.9M | -$17.1M | -$10.4M | -$13.7M |
| Impôts | 0 | 0 | 0 | $20.0M | 0 | $259000 | -$110000 | 0 | $2.1M | $437000 |
| Résultat Net | -$28.2M | -$22.5M | -$10.2M | -$47.2M | -$13.6M | -$58.3M | -$108.8M | -$17.1M | -$15.8M | -$13.6M |
| BPA | $-1294738.36 | $-193194.38 | $-3061.23 | $-1210.28 | $-60.20 | $-69.60 | $-74.01 | $-5.11 | $-2.86 | $-2.16 |
| BPA Dilué | $-1294738.36 | $-193194.38 | $-3061.23 | $-1210.28 | $-60.20 | $-69.60 | $-74.01 | $-5.11 | $-2.86 | $-2.16 |
| Actions en Circulation (Diluées) | $22 | $117 | $3328 | $38972 | $230000 | $840000 | $1.5M | $3.3M | $5.5M | $6.3M |
Prix
| Prix | $1.97 |
| Capitalisation | $21M |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: ADAP · ALUR · ANL · BFRI · EKSO · GOVX · NVNO
Explorer le secteur: Healthcare · Drug Manufacturers - Specialty & Generic
Plus de sections de AYTU: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions